Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel

Annals of Nuclear Medicine

Volumn 13, Issue 3, 1999, Pages 169-174

  Inoue, Tomio ^a,b   Li, Chun ^a   Yang, David J ^a   Higuchi, Tetsuya ^a   Oriuchi, Noboru ^a   Yu, Dongfang ^a   Milas, Luka ^a   Hunter, Nancy ^a   Wallace, Sidney ^a   Kim, E Edmund ^a   Podoloff, Donald A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Chemotherapy; In 111 DTPA paclitaxel; Paclitaxel

Indexed keywords

CREMOPHOR; INDIUM 111; PACLITAXEL; PENTETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG MONITORING; FEMALE; FIBROSARCOMA; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; SCINTIGRAPHY; SQUAMOUS CELL CARCINOMA;

EID: 0032765745     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164857     Document Type: Article

References (21)

1. Evans WE, Relling MV. Clinical pharmacokinetics-pharmacodynamics of anticancer drugs. Clin Pharmacokinet 16:327-336, 1989.
2. Moretti JL, Caglar M, D-Cordobes M, Morere JF. Can nuclear medicine predict response to chemotherapy? Eur J Nucl Med 22: 91-100, 1995.
3. Rowinsky EK, Donehower RC. Paclitaxel (Taxol). New Engl J Med 332: 1004-1014, 1995.
4. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 277: 665-667, 1979.
5. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, et al. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83: 1797-1805, 1991.
6. Thigpen JT, Blessing JA, Ball H, Hummel SJ, Barrett RJ. Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy. A Gynecological Oncology Group study. J Clin Oncol 12: 1748-1753, 1994.
7. Li C, Yu DF, Inoue T, Yang DJ, Tansey W, Liu CW, et al. Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors. J Nucl Med 38: 1042-1047, 1997.
8. Milas L, Hunter NR, Mason KA, Kurdoglu B, Peters LJ. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 54: 3506-3510, 1994.
9. Stone HB, Milas L. Modification of radiation response of murine tumors by misonidazole (Ro 07-0582), host immune capability, and Corynebacterium parvum. J Natl Cancer Inst 60: 887-893, 1978.
10. Stephens LC, Ang KK, Shultheiss TE, Milas L, Meyn RE. Apoptosis in irradiated murine tumors. Radiat Res 127: 308-316, 1991.
11. 3H]thymidine, and gallium-67. J Nucl Med 32: 2118-2123, 1991.
12. Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, et al. Assessment of response to cancer therapy using fluorine-18-fluoro-deoxyglucose and positron emission tomography. J Nucl Med 32: 1655-1660, 1991.
13. Sasaki Y. Monitoring tumor radiotherapy. J Nucl Med 32: 2124-2125, 1991.
14. 131I-5-iodo-2-deoxyuridine by malignant tumors in man. Br J Cancer 63: 134-135, 1991.
15. Sapir EE, Bettman L, Iosilevsky G, Milshtein D, Frenkel A, Kolodny GM, et al. SPECT quantification of cobalt-57-bleomycin to predict treatment response and outcome of patients with lung cancer. J Nucl Med 35: 1129-1133, 1994.
16. 18F]fluorouracil in sensitive versus resistant lymphocytic leukemia in mice. Cancer Res 37: 2306-2308, 1977.
17. Young D, Vine E, Ghanbarpour A, Shani J, Siesmen JK, Wolf W. Metastatic and distribution studies with radiolabeled 5-fluorouracil. J Nucl Med 21: 1-7, 1982.
18. Horwitz SB, Cohen D, Rao S, Ringel I, Shen H, Yang CH. Taxol: Mechanism of action and resistance. Monogr Natl Cancer Inst Monogr 15: 55-61, 1993.
19. Roy SN, Horwitz SB. A phosphoglycoprotein associated with taxol-resistance in J774.2 cells. Cancer Res 45: 3856-3863, 1985.
20. Saito Y, Milross CG, Hittleman WN, Li D, Jibu T, Peters LJ, et al. Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction. Int J Rad Oncol Biol Phys 38: 623-631, 1997.
21. Fujibayashi Y, Takemura Y, Matsumoto K, Wada K, Yonekura Y, Konishi J, et al. High myocardial accumulation of radioiodinated digoxin derivatives: a possible Na,K-ATPase imaging agent. J Nucl Med 33: 545-549, 1992.